Accure Therapeutics (private company)

See something wrong or missing? Let us know
Offices:
Barcelona
Category:
Biotech Pharma
Business model:
B2B
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Accure Therapeutics is a R&D pharma company dedicated to developing medicines to treat patients suffering from Central nervous system (CNS) diseases, a major medical challenge.

Companies with similar profile to Accure Therapeutics:

CompanyCriteria
Spain Sanifit Therapeutics
56%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: Alta Life Sciences | FCR
  • Minim one investor from outside Scandinavia: Yes
Finland Desentum
54%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Oncomatryx
54%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Gradientech
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Sweden iCellate
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Denmark NMD Pharma
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark STipe Therapeutics
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden OxThera
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Pulmobiotics S.L
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark AFYX Therapeutics
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark Octarine Bio
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark Cirqle Biomedical
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway Sorbwater Technology
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Elypta
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Biosyntia
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Monocl
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden EnginZyme
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Amadix
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark CysBio
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes